Loading...

MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors

Advances in the use of targeted and immune therapies have revolutionized the clinical management of melanoma patients, prolonging significantly their overall and progression-free survival. However, both targeted and immune therapies suffer limitations due to genetic mutations and epigenetic modifica...

Full description

Saved in:
Bibliographic Details
Published in:Int J Mol Sci
Main Authors: Motti, Maria Letizia, Minopoli, Michele, Di Carluccio, Gioconda, Ascierto, Paolo Antonio, Carriero, Maria Vincenza
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7352536/
https://ncbi.nlm.nih.gov/pubmed/32604720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21124544
Tags: Add Tag
No Tags, Be the first to tag this record!